EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (Q33284736)
scientific article published on 15 May 2007
Language:
Current Data About EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
(P31) (Q13442814)
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P50) (Q42326409)
(P1932) D Isenberg
(P1545) 11

(Q6251482)
(P1545) 2
(P1932) J P A Ioannidis
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q58049734)
(P1545) 20
(P1932) C Gordon
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q47265013)
(P1545) 19
(P1932) R van Vollenhoven
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q53547424)
(P1545) 5
(P1932) R Cervera
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q73304219)
(P1545) 18
(P1932) A Tincani
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q73418907)
(P1545) 13
(P1932) M Khamashta
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q73474655)
(P1545) 7
(P1932) J Font
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q73477457)
(P1545) 4
(P1932) S Bombardieri
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q73305204)
(P1545) 14
(P1932) J C Piette
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(Q87375577)
(P1545) 12
(P1932) C G M Kallenberg
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P304) 195-205
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P407) (Q1860)

(P433) 2
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P478) 67
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P577) Tuesday, May 15, 2007
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P921) (Q1485)
(P887)

(P1433) (Q4767876)
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P1476) "EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics" (language: en)
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

(P2093) G Bertsias
(P1545) 1
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

J Boletis
(P1545) 3
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

C Dostal
(P1545) 6
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

I M Gilboe
(P1545) 8
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

F Houssiau
(P1545) 9
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

T Huizinga
(P1545) 10
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

M Schneider
(P1545) 15
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

J Smolen
(P1545) 16
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

G Sturfelt
(P1545) 17
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

D T Boumpas
(P1545) 21
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
(P1545) 22
(P248)
(P698) 17504841
(P813) Tuesday, July 25, 2017

other details
description scientific article published on 15 May 2007

External Links
(P356) 10.1136/ARD.2007.070367
(P698) 17504841
(P5875) 6327239